These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 21839907)

  • 1. [The cost of diabetes in Latin America: evidence from Mexico].
    Arredondo A; De Icaza E
    Value Health; 2011; 14(5 Suppl 1):S85-8. PubMed ID: 21839907
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Financial requirements for health services demands for diabetes and hypertension in Mexico: 2001-2003].
    Arredondo A
    Rev Invest Clin; 2001; 53(5):422-9. PubMed ID: 11795108
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Health care costs and financial consequences of epidemiological changes in chronic diseases in Latin America: evidence from Mexico.
    Arredondo A; Zúñiga A; Parada I
    Public Health; 2005 Aug; 119(8):711-20. PubMed ID: 15885723
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Economic consequences of epidemiological changes in diabetes in middle-income countries: the Mexican case.
    Arredondo A; Zúñiga A
    Diabetes Care; 2004 Jan; 27(1):104-9. PubMed ID: 14693974
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Health disparities from economic burden of diabetes in middle-income countries: evidence from México.
    Arredondo A; Reyes G
    PLoS One; 2013; 8(7):e68443. PubMed ID: 23874629
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Challenges on the epidemiological and economic burden of diabetes and hypertension in Mexico.
    Arredondo A; Orozco E; Alcalde-Rabanal J; Navarro J; Azar A
    Rev Saude Publica; 2018; 52():23. PubMed ID: 29489993
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Costs and epidemiological changes of chronic diseases: implications and challenges for health systems.
    Arredondo A; Aviles R
    PLoS One; 2015; 10(3):e0118611. PubMed ID: 25781625
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiologic changes and economic burden of hypertension in Latin America: evidence from Mexico.
    Arredondo A; Zúñiga A
    Am J Hypertens; 2006 Jun; 19(6):553-9. PubMed ID: 16733225
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epidemiological changes and financial consequences of hypertension in Latin America: implications for the health system and patients in Mexico.
    Arredondo A; Zuñiga A
    Cad Saude Publica; 2012 Mar; 28(3):497-502. PubMed ID: 22415182
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Epidemiological and financial indicators of hypertension in older adults in Mexico: challenges for health planning and management in Latin America.
    Arredondo A; Duarte MB; Cuadra SM
    Int J Health Plann Manage; 2017 Apr; 32(2):e121-e136. PubMed ID: 27238949
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Health services utilization and costs of the insured and uninsured under the formal sector social health insurance scheme in Enugu metropolis South East Nigeria.
    Ujunwa FA; Onwujekwe O; Chinawa JM
    Niger J Clin Pract; 2014; 17(3):331-5. PubMed ID: 24714012
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Economic evaluation of the demand of medical care for mental health in Mexico: schizophrenia and depression, 1996-2000].
    Arredondo A; Ramos R; Zúñiga A
    Rev Invest Clin; 2003; 55(1):43-50. PubMed ID: 12708163
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Estimation of health-care costs for work-related injuries in the Mexican Institute of Social Security.
    Carlos-Rivera F; Aguilar-Madrid G; Gómez-Montenegro PA; Juárez-Pérez CA; Sánchez-Román FR; Durcudoy Montandon JE; Borja-Aburto VH
    Am J Ind Med; 2009 Mar; 52(3):195-201. PubMed ID: 19097082
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Costs of temporary disability in Spain related to diabetes mellitus and its complications].
    Vicente-Herrero MT; Terradillos García MJ; Capdevila García LM; Ramírez Iñiguez de la Torre MV; López-González AA
    Endocrinol Nutr; 2013 Oct; 60(8):447-55. PubMed ID: 23726468
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Challenges of the epidemiological and economic burdens associated with hypertension in middle income countries: evidence from Mexico.
    Arredondo A; Cuadra SM; Duarte MB
    BMC Public Health; 2015 Nov; 15():1106. PubMed ID: 26546356
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Catastrophic health expenses and impoverishment of households of patients with rheumatoid arthritis.
    Álvarez-Hernández E; Peláez-Ballestas I; Boonen A; Vázquez-Mellado J; Hernández-Garduño A; Rivera FC; Teran-Estrada L; Ventura-Ríos L; Ramos-Remus C; Skinner-Taylor C; Goycochea-Robles MV; Bernard-Medina AG; Burgos-Vargas R
    Reumatol Clin; 2012; 8(4):168-73. PubMed ID: 22704914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The challenges of the family planning program].
    Alarcon F; Mojarro O
    Demos; 1991; (4):11-2. PubMed ID: 12158037
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The relevance of unrelated costs internal and external to the healthcare sector to the outcome of a cost-comparison analysis of secondary prevention: the case of general colorectal cancer screening in the German population.
    Tscheulin DK; Drevs F
    Eur J Health Econ; 2010 Apr; 11(2):141-50. PubMed ID: 19449159
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Diabetes, a global public health challenge with a high epidemiological and economic burden on health systems in Latin America.
    Arredondo A; Azar A; Recamán AL
    Glob Public Health; 2018 Jul; 13(7):780-787. PubMed ID: 28447537
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Direct service costs of diabetes mellitus hospitalisations in the Mexican Institute of Social Security].
    Salas-Zapata L; Palacio-Mejía LS; Aracena-Genao B; Hernández-Ávila JE; Nieto-López ES
    Gac Sanit; 2018; 32(3):209-215. PubMed ID: 27495830
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.